UBS Group’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.5K | Sell |
|
|||||
|
2025
Q1 | $196K | Buy |
|
|||||
|
2024
Q4 | $236K | Buy |
|
|||||
|
2024
Q3 | $58K | Buy |
|
|||||
|
2024
Q2 | $87.2K | Sell |
|
|||||
|
2024
Q1 | $499K | Sell |
|
|||||
|
2023
Q4 | $2.24M | Buy |
|
|||||
|
2023
Q3 | $570K | Sell |
|
|||||
|
2023
Q2 | $886K | Sell |
|
|||||
|
2023
Q1 | $896K | Sell |
|
|||||
|
2022
Q4 | $1.97M | Buy |
|
|||||
|
2022
Q3 | $277K | Buy |
|
|||||
|
2022
Q2 | $49K | Sell |
|
|||||
|
2022
Q1 | $989K | Sell |
|
|||||
|
2021
Q4 | $2.87M | Buy |
|
|||||
|
2021
Q3 | $193K | Buy |
|
|||||
|
2021
Q2 | $196K | Sell |
|
|||||
|
2021
Q1 | $199K | Buy |
|
|||||
|
2020
Q4 | $160K | Sell |
|
|||||
|
2020
Q3 | $626K | Buy |
|
|||||
|
2020
Q2 | $451K | Buy |
|
|||||
|
2020
Q1 | $34K | Sell |
|
|||||
|
2019
Q4 | $81K | Buy |
|